Genetic Testing for Cancer Risk
Diagnostics · VEI Clinic, Gangnam, Seoul

Genetic testing for inherited cancer risk is arranged case by case. Tell us about your personal and family history, and your doctor will explain whether testing is appropriate, which laboratory panel would be used and how results are reviewed.
What the BRCA Genes Do
BRCA1 and BRCA2 are genes everyone carries, and the proteins they make help repair damaged DNA. A harmful change (pathogenic variant) in either BRCA gene raises the lifetime risk of breast and ovarian cancer well above average, and these cancers tend to appear at younger ages in carriers.
A BRCA variant also raises the risk of prostate cancer, pancreatic cancer and breast cancer in men, so the question matters for men as well as women. A variant can come from either the mother's or the father's side of the family, and each child of a carrier has a 50% chance of inheriting it. Hereditary cancer panels usually test BRCA1 and BRCA2 together with other genes linked to inherited cancer risk.
Who Should Consider Testing
Genetic testing for disease risk is most useful when a result would change your screening or prevention plan, so expert guidelines focus on people who are more likely to carry a harmful variant. Testing may be worth discussing if any of these apply:
- A blood relative with a known BRCA or other hereditary cancer variant
- Breast cancer at age 50 or younger in you or a close relative
- Ovarian, fallopian tube or primary peritoneal cancer in you or a close relative
- Male breast cancer, pancreatic cancer, or metastatic or high-risk prostate cancer in you or a close relative
- Ashkenazi Jewish ancestry
- A tumor test that found a BRCA change, which a blood or saliva test can confirm as inherited or not
For people without a suggestive personal or family history, BRCA testing is not recommended as a routine screen, and it is not recommended for children under 18.
How Testing Works and What Results Mean
Testing uses a blood or saliva sample, because an inherited variant is present in every cell of the body. Talking the test through before and after, with your doctor and a genetic counselor when needed, helps you understand what a result would mean for you and for your relatives. Results fall into three groups:
- Positive: a harmful variant was found. Your risk is higher, but the result cannot tell whether or when cancer will develop. Earlier or more frequent screening and risk-reducing options are then planned with the relevant specialists.
- Negative: if a variant is already known in your family and you did not inherit it, this is reassuring for that variant. If no family variant is known, a negative result does not cancel the risk suggested by your family history.
- Variant of uncertain significance (VUS): a change whose effect is not yet known. Most are later reclassified as harmless, so care is guided by your family history in the meantime.
Some consumer DNA kits check only a few of the many possible BRCA variants, so a negative result from one does not rule out a harmful change. Bring any earlier report so the doctor can see exactly what was tested. The cost depends mainly on whether a single known family variant or a multigene panel is tested and on the laboratory used, and you receive an itemized quote after the consultation.
Plan your visit
3F, Beneheim City, 162 Apgujeong-ro, Gangnam-gu, Seoul. About a one-minute walk from Exit 5 of Apgujeong Station (Line 3).
- Mon · Thu · Fri
- 10:00 – 19:00
- Tuesday
- 10:00 – 20:00
- Saturday
- 10:00 – 16:00
- Lunch break
- 13:00 – 14:00, except Saturday
- Wed · Sun
- Closed
Bring your passport or ID, a list of medicines and allergies, and any recent results. For chest pain, severe breathing difficulty or signs of stroke, call 119 or go to the nearest emergency department.

